Hematerra Technologies, LLC
Baltimore, MD
- UEI
- JQ4KS47ALUU9
- CAGE
- 8C4E8
- Primary NAICS
- 541512 Computer Systems Design Services
- SAM.gov registration
- Expired
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
- Champion Medical Technologies, Inc. · Baltimore, MD KLV4JGZNZJE8
- Ottawa, ON RW6VN6CJHA47
-
- SAM.gov registration date
- Physical address
- 180 W Ostend St #267a, Baltimore, MD 21230, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $132,519 |
| FY2025 | $128,660 |
| FY2024 | $124,913 |
| FY2023 | $187,390 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $132,519 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Blood Bank Computer Systems, Inc. | Bonney Lake, WA | 541511 Custom Computer Programming Services |
| SCC Soft Computer | Clearwater, FL | 513210 Software Publishers |
| Invita Healthcare Technologies, Inc. | Baltimore, MD | 513210 Software Publishers |
| Stacs DNA Inc. | Ottawa, ON | 541511 Custom Computer Programming Services |
| American Assc Of Blood Bank | Bethesda, MD | 813920 Professional Organizations |
About the company
Hematerra Technologies, LLC, a for-profit limited liability company based in Baltimore, Maryland, develops and maintains blood-bank software systems and medical device tracking solutions for federal healthcare agencies as a prime contractor, operating exclusively in the full-and-open (non-set-aside) space. The company holds two named subsidiaries — Champion Medical Technologies, Inc., and Stacs DNA Inc. — and specializes in healthcare IT and inventory management for transfusion medicine operations.
Hematerra's federal footprint is highly concentrated with a single customer: the National Institutes of Health Clinical Center accounts for 8 awards totaling $788 thousand in combined potential value, or 86% of the vendor's total federal revenue. The portfolio comprises six software maintenance and support purchase orders for Hematerra's HemaComply suite (HemaComply-Lab, HemaComply-Equipment Manager, HemaControl1, and HemaConnect Donor System), all supporting the NIH Clinical Center's Department of Transfusion Medicine and blood bank operations under FDA licensing and AABB accreditation. Representative work includes $132.5 thousand for preventative maintenance and software support (May 2026 – April 2027), $128.7 thousand for HemaComply software maintenance (May 2025 – April 2026), $124.9 thousand for maintenance of HemaConnect and related systems (May 2024 – April 2025), and $121.3 thousand for HemaConnect and HemaComply support (May 2023 – April 2024). A single award from the NIH Office of Logistics and Acquisition Operations for $132.5 thousand rounds out recent activity. All awards carry firm fixed-price purchase order structures with no set-aside designation.
Activity remains flat at one award per year from 2022 through 2026, with combined potential value of $921 thousand across nine prime awards since 2019. One award worth $132.5 thousand reaches ultimate completion within the next twenty-four months. Hematerra does not hold seats on government-wide vehicles or multiple-award IDIQs; all work flows through direct purchase orders from NIH. The vendor operates exclusively as a prime contractor with zero subcontract activity in the source data, and carries no SBA certifications (8(a), HUBZone, SDVOSB, WOSB, or other set-aside designations) across its federal footprint. The narrow customer base and single-agency concentration present recompete risk centered on NIH's continued renewal of annual maintenance and support services for blood-banking systems.
Quick answers
Is Hematerra Technologies, LLC registered in SAM.gov?
Hematerra Technologies, LLC's SAM.gov registration expired on September 10, 2026.
How much has Hematerra Technologies, LLC received in federal contracts?
Federal contracts obligated $128,660 to Hematerra Technologies, LLC in fiscal year 2025 and $573,482 in fiscal years 2023 through 2027.
How does Hematerra Technologies, LLC rank among federal contractors?
Hematerra Technologies, LLC ranked #16 in PSC H270, #38 in PSC Q702 and #40 in PSC 7J in FY2025.
What is Hematerra Technologies, LLC's most recent federal award?
Hematerra Technologies, LLC's most recent federal contract award is 26-004481 preventative maintenance agreement for hema comply equipment POP 05/01/2026 to 04/30/2027 (75N98026P00419), from Office of Logisitics and Acquisition Operations (NIH), on May 1, 2026.
On GovTribe
See Hematerra Technologies, LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors